Showing results (71-80 of 218) with videos related to

Sort By:
Pageof 22
Clinical Proteomics|August 13, 2021
Robust optimization of SWATH-MS workflow for human blood serum proteome analysis using a quality by design approachEdith Serrano-Blesa, Andrew Porter, Dennis W Lendrem, et al.
NPJ Digital Medicine|October 8, 2025
Systematic review: digital biomarkers of fatigue in chronic diseasesNana Yaw Aboagye, Chloe Hinchliffe, Silvia Del Din, et al.
Arthritis Research & Therapy|February 9, 2012
Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow upMark Houseman, Catherine Potter, Nicola Marshall, et al.
Arthritis and Rheumatism|September 29, 2011
Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohortDarren Plant, Rita Prajapati, Kimme L Hyrich, et al.
Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.
Arthritis and Rheumatism|September 24, 2010
Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responsesJeroen N Stoop, Rachel A Harry, Alexei von Delwig, et al.
Arthritis and Rheumatism|February 1, 2006
The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse modelAlexei von Delwig, Daniel M Altmann, John D Isaacs, et al.
Rheumatology (Oxford, England)|March 27, 2012
Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responsesAmy E Anderson, Alice R Lorenzi, Arthur Pratt, et al.
Annals of the Rheumatic Diseases|November 23, 2006
T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic miceAlexei von Delwig, Daniel M Altmann, Fraser G Charlton, et al.
Rheumatology (Oxford, England)|March 10, 2009
A novel paradigm for dendritic cells as effectors of cartilage destructionRachel L Lakey, Tanya G Morgan, Andrew D Rowan, et al.
Pageof 22